Next Article in Journal
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors
Next Article in Special Issue
Influence of Different Amino Acids on the Aerosolization, Stability and Cytotoxicity of Spray-Dried Cannabidiol Dry Powder for Inhalation
Previous Article in Journal
Nanostructured Lipid Carriers for Sustained Release and Enhanced Delivery of Vanda coerulea Protocorm Extract
Previous Article in Special Issue
Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(8), 1077; https://doi.org/10.3390/pharmaceutics17081077
Action Date Notes Link
article html file updated 22 August 2025 10:15 CEST Update https://www.mdpi.com/1999-4923/17/8/1077/html
article pdf uploaded. 22 August 2025 10:12 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/1077/pdf
article xml uploaded. 22 August 2025 10:12 CEST Update https://www.mdpi.com/1999-4923/17/8/1077/xml
article xml file uploaded 22 August 2025 10:12 CEST Update -
article html file updated 21 August 2025 13:09 CEST Original file -
article pdf uploaded. 21 August 2025 13:07 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/1077/pdf-vor
article xml uploaded. 21 August 2025 13:07 CEST Update -
article xml file uploaded 21 August 2025 13:07 CEST Original file -
article pdf uploaded. 20 August 2025 14:28 CEST Version of Record https://www.mdpi.com/1999-4923/17/8/1077/pdf-vor
Back to TopTop